
BIOLASE BIOL
Quartalsbericht 2024-Q3
hinzugefügt 07.11.2024
BIOLASE Operativer Cashflow 2011-2026 | BIOL
Operativer Cashflow Jährlich BIOLASE
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -14.1 M | -26.8 M | -16.7 M | -12.8 M | -12.7 M | -14.1 M | -18.4 M | -10.6 M | - | - | -9.3 M | -1.66 M | -13.3 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -1.66 M | -26.8 M | -13.7 M |
Operativer Cashflow Vierteljährlich BIOLASE
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -5.94 M | - | - | - | -5.66 M | - | -21.2 M | -14.6 M | -8.02 M | - | -13.6 M | -10 M | -6.5 M | - | -11.4 M | -9.34 M | -4.13 M | - | -8.07 M | -6.63 M | -5.03 M | - | -10.6 M | -8.34 M | -4.76 M | - | -14.2 M | -10.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2.82 M | 1.9 M | -3.53 M | -3.27 M | -593 K | - | -11.3 M | -7.1 M | -5.06 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.9 M | -21.2 M | -7.81 M |
Operativer Cashflow anderer Aktien in der Medizinische Geräte
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AdaptHealth Corp.
AHCO
|
602 M | $ 13.17 | 0.46 % | $ 1.78 B | ||
|
Allied Healthcare Products
AHPI
|
-4.1 M | - | 3.58 % | $ 2.21 M | ||
|
Eargo
EAR
|
-117 M | - | - | $ 10.2 M | ||
|
Delcath Systems
DCTH
|
22.5 M | $ 10.8 | 4.05 % | $ 387 M | ||
|
Apollo Endosurgery
APEN
|
-31.3 M | - | - | $ 475 M | ||
|
Second Sight Medical Products
EYES
|
-24.3 M | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
11.4 M | $ 25.6 | -0.43 % | $ 216 M | ||
|
Avinger
AVGR
|
-14.4 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
3.19 M | - | - | $ 3.31 B | ||
|
EDAP TMS S.A.
EDAP
|
-13.6 M | $ 3.47 | 4.52 % | $ 130 M | ||
|
Aziyo Biologics
AZYO
|
-44.8 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
-10.4 M | - | 37.08 % | $ 85.7 M | ||
|
Helius Medical Technologies
HSDT
|
-10.4 M | $ 2.12 | 3.92 % | $ 1.29 M | ||
|
Inspire Medical Systems
INSP
|
117 M | $ 56.7 | 1.0 % | $ 1.67 B | ||
|
Conformis
CFMS
|
-50.2 M | - | - | $ 16.4 M | ||
|
LivaNova PLC
LIVN
|
254 M | $ 61.0 | 1.5 % | $ 3.33 B | ||
|
ClearPoint Neuro
CLPT
|
-23.9 M | $ 11.37 | 1.7 % | $ 322 M | ||
|
Cardiovascular Systems
CSII
|
-24.3 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
-12.4 M | $ 0.61 | 0.36 % | $ 38 M | ||
|
Invacare Corporation
IVC
|
-55.3 M | - | - | $ 24.7 M | ||
|
IRIDEX Corporation
IRIX
|
-2.12 M | $ 1.03 | - | $ 17.4 M | ||
|
Dynatronics Corporation
DYNT
|
301 K | - | 14.99 % | $ 929 K | ||
|
Neovasc
NVCN
|
-27.1 M | - | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-4.85 M | $ 15.65 | 3.92 % | $ 367 M | ||
|
Butterfly Network
BFLY
|
-41.7 M | $ 5.4 | 12.97 % | $ 1.14 B | ||
|
GBS
GBS
|
-9.68 M | - | -0.57 % | $ 7.12 M | ||
|
Sintx Technologies
SINT
|
-8.57 M | $ 2.41 | 14.22 % | $ 6.68 M | ||
|
Globus Medical
GMED
|
753 M | $ 91.34 | 1.29 % | $ 12.4 B | ||
|
TransMedics Group
TMDX
|
193 M | $ 100.01 | -0.77 % | $ 3.4 B | ||
|
NanoVibronix
NAOV
|
-9.37 M | - | - | $ 1.08 M | ||
|
CONMED Corporation
CNMD
|
171 M | $ 36.8 | 0.38 % | $ 1.14 B | ||
|
Integer Holdings Corporation
ITGR
|
196 M | $ 84.03 | -5.06 % | $ 2.92 B | ||
|
Stryker Corporation
SYK
|
5.04 B | $ 294.73 | -6.47 % | $ 113 B | ||
|
Edwards Lifesciences Corporation
EW
|
1.6 B | $ 83.98 | 0.57 % | $ 49.1 B | ||
|
Tandem Diabetes Care
TNDM
|
-9.72 M | $ 19.41 | -0.61 % | $ 1.32 B | ||
|
LENSAR
LNSR
|
-14.8 M | $ 5.61 | 7.27 % | $ 67.1 M | ||
|
Pulmonx Corporation
LUNG
|
-32.4 M | $ 1.35 | 5.47 % | $ 54.9 M | ||
|
MiMedx Group
MDXG
|
74 M | $ 3.68 | 9.52 % | $ 544 M | ||
|
Myomo
MYO
|
-14.5 M | $ 0.9 | 4.16 % | $ 37.7 M |